NL-OMON38904已完成不适用
Efficacy analysis of a novel compound in a humanized mouse model for psoriasis and development of the humanized mouse model - Pre-clinical efficacy of a novel compound in psoriasis
TNO0 个研究点目标入组 33 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 33
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Psoriasis patients: Adults (m/f) with a mild to moderate form of psoriasis vulgaris (PASI score of maximal 18 and minimum BSA of 3%). Patients are allowed to use local corticosteroids or ointments to prevent dry skin (see Appendix 2).
排除标准
- •These patients have not received light therapy or another form of systemic treatment (methotrexate, cyclosporin A, anti-TNF treatments). Gender or age of the adults are not exclusion criteria (see Appendix 2).
研究者
相似试验
已完成
不适用
Efficacy analysis of a novel compound in a humanized mouse model of psoriasisflaking diseasePsoriasis1000381610014982NL-OMON37226TNO16
已完成
不适用
Efficacy of two novel compounds in a humanized mouse model of psoriasisflaking diseasepsoriasis1000381610014982NL-OMON35972TNO29
招募中
不适用
Efficacy of a three novel compounds in a humanized mouse model of psoriasisflaking diseasepsoriasis1000381610014982NL-OMON35935Pfizer24
已完成
不适用
Efficacy of a proprietary compound B in a humanized mouse model of psoriasisflaking diseasepsoriasis1000381610014982NL-OMON34173TNO26
已完成
不适用
A safety and efficacy study of a novel formulation of prednisolone metasulfobenzoate (predocol) in the induction of remission and maintenance in patients with ulcerative colitisAcute exacerbations of ulcerative colitisNutritional, Metabolic, EndocrineUlcerative colitisISRCTN14133410Flexpharm Ltd. (UK)180